Srdan (University of Texas MD Anderson Cancer Center Verstovsek Houston USA),Hans Michael (University of Frankfurt Kvasnicka Germany),Juergen (University Cologne Thiele Germany)
(1)
This succinct resource provides an ideal balance of the biology and practical therapeutic strategies for classic and non-classic BCR-ABL-negative myeloproliferative neoplasms. Utilizing current World